| http://www.w3.org/ns/prov#value | - Flunisyn??? is also designed to address the key demands of main regulatory and governing bodies such as the US Food & Drug Administration (FDA), the European Medicines Agency (EMA), and World Health Organization (WHO) which include: prophylactic protection against multiple strains of both seasonal and pandemic influenza, effectiveness for at-risk groups, amenability to repeated dosing, potential f
|
